StayCurrentMD · Complications after proctocolectomy and ileal pouch-anal anastomosis in pediatric patients: A systematic review
Article1 min read·Published Oct 2018Older

Complications after proctocolectomy and ileal pouch-anal anastomosis in pediatric patients: A systematic review

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Oct 2018 · 1 min read

In brief

In brief

Systematic review of 763 pediatric patients undergoing IPAA reveals that UC patients experience higher pouch loss rates (10.6%) compared to FAP patients (1.5%), with pouchitis being the most common complication (36.4%). Major complications like anastomotic leak and abscess remain rare, but disease-specific factors significantly impact outcomes.

Written by the GCMD Library team from the article.

Abstract

Background/purpose

Colectomy with ileal pouch-anal anastomosis (IPAA) is the standard of care for patients with familial adenomatous polyposis (FAP) and refractory ulcerative colitis (UC). The rates of postoperative complications are not well established in children. The objective of this systematic review is to establish benchmark data for morbidity after pediatric IPAA.

Methods

PubMed, Embase, and The Cochrane Library were searched for studies of colectomy with IPAA in patients ≤21 years old. UC studies were limited to the anti-tumor necrosis factor-α agents era (1998–present). All postoperative complications were extracted.

Results

Thirteen studies met the inclusion criteria (763 patients). Compared to patients with FAP, UC patients had a higher prevalence of pouch loss (10.6% vs. 1.5%). Other major complications such as anastomotic leak, abscess, and fistula were uncommon (mean prevalence 4.9%, 4.2%, and 5.0%, respectively, for patients with UC; 8.7%, 4.2%, and 4.3% for FAP). The most frequent complication was pouchitis (36.4% of UC patients).

Conclusions

Devastating complications from colectomy and IPAA are rare, but patients with UC have poorer outcomes than those with FAP. Much of the morbidity may therefore stem from patient or disease factors. Multicenter, prospective studies are needed to identify modifiable risks in patients with UC undergoing IPAA.

Level of evidence

Prognostic, level II.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →